Growth Metrics

Omeros (OMER) Free Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63.59%
Dec 31, 2025 -115.79%
Sep 30, 2025 15.97%
Jun 30, 2025 38.77%
Mar 31, 2025 -23.71%
Dec 31, 2024 9.52%
Sep 30, 2024 30.40%
Jun 30, 2024 -10.10%
Mar 31, 2024 -19.73%
Dec 31, 2023 -6.92%
Sep 30, 2023 -0.20%
Jun 30, 2023 -118.69%
Mar 31, 2023 787.30%
Dec 31, 2022 3.94%
Sep 30, 2022 -35.79%
Jun 30, 2022 -28.14%
Mar 31, 2022 16.93%
Dec 31, 2021 23.04%
Sep 30, 2021 14.15%
Jun 30, 2021 31.26%
Mar 31, 2021 -118.75%
Dec 31, 2020 47.43%
Sep 30, 2020 7.23%
Jun 30, 2020 -309.92%
Mar 31, 2020 60.02%
Dec 31, 2019 -204.59%
Sep 30, 2019 54.69%
Jun 30, 2019 -27.08%
Mar 31, 2019 46.95%
Dec 31, 2018 33.04%
Sep 30, 2018 -18.80%
Jun 30, 2018 -171.04%
Mar 31, 2018 -175.14%
Dec 31, 2017 62.84%
Sep 30, 2017 -33.62%
Jun 30, 2017 34.22%
Mar 31, 2017 -17.07%
Dec 31, 2016 3.12%
Sep 30, 2016 12.21%
Jun 30, 2016 22.85%
Mar 31, 2016 0.15%
Dec 31, 2015 -13.59%
Sep 30, 2015 11.99%
Jun 30, 2015 4.67%
Mar 31, 2015 -11.26%
Dec 31, 2014 1.54%
Sep 30, 2014 -4.48%
Jun 30, 2014 -36.99%
Mar 31, 2014 -2,970.25%
Dec 31, 2013 96.73%
Sep 30, 2013 -18.01%
Jun 30, 2013 -3.73%
Mar 31, 2013 31.35%
Dec 31, 2012 -76.09%
Sep 30, 2012 16.15%
Jun 30, 2012 -60.19%
Mar 31, 2012 24.66%
Dec 31, 2011 -79.92%
Sep 30, 2011 39.82%
Jun 30, 2011 20.11%
Mar 31, 2011 -230.16%
Dec 31, 2010 208.63%